Literature DB >> 30527066

Measles outbreak in Brazil, 2018.

Luciano Z Goldani1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30527066      PMCID: PMC9427970          DOI: 10.1016/j.bjid.2018.11.001

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


× No keyword cloud information.
Measles infection is caused by a single-stranded, negative-strand RNA respiratory virus of the family Paramyxoviridae and genus Morbillivirus. Measles virus is a highly contagious acute febrile disease associated with a characteristic erythematous, maculopapular rash. Considered one of the most communicable illnesses, measles is transmitted by airborne droplets or via direct contact with secretions from the nose, mouth, and throat of infected individuals. Measles was a leading global cause of child morbidity and mortality and responsible for more than 2 million deaths annually before the increase in global measles vaccine coverage in the 1980s. Outbreaks can occur in populations where fewer than 10% of people are not immune to the measles virus. Measles was declared eliminated from the Americas in 2016, following the declaration of rubella and congenital rubella syndrome elimination in 2015. During 2017 and 2018, there have been many countries in the Americas Region reporting confirmed cases of measles including Antigua and Barbuda, Brazil, Canada, Guatemala, Mexico, Peru, United States, Venezuela and Argentina. Venezuela's ongoing health crisis accounted for the majority of reported cases. In Brazil, there is an ongoing measles outbreak. From January to November 2018, there were 2,801 confirmed measles cases in Brazil. The vast majority of cases were reported in Amazonas (2,357 cases) and Roraima (345 cases) States in northern Brazil. Indigenous populations living close to the Venezuelan borders are particularly vulnerable to measles outbreaks. There were 77 confirmed cases among indigenous Yanomami and Ye’kuna communities in Roraima and Amazonas states, according to Pan American Health Organization. The outbreak is linked to genotype D8 importation from Venezuela, which is the same one that circulates in the Venezuela outbreak of measles since 2017. Measles have entered the country with Venezuelan migrants, but it was the low number of vaccinated Brazilians that helped the disease spread. Some isolated cases and related to the importation from Venezuela were identified in the states of São Paulo (3), Rio de Janeiro (19); Rio Grande do Sul (43); Rondônia (2), Pernambuco (4), Pará (23), Federal District (1) and Sergipe (4). To date, in Brazil, 12 measles deaths have been confirmed, with 6 deaths in the state of Roraima, 6 in Amazonas and two in Pará State. Vaccination strategies and other actions are being implemented to control the outbreak by local and federal authorities. According to the Ministry of Health of Brazil, all states with confirmed cases of measles reached the minimum target of 95% of vaccine coverage, with the exception of the Federal District. Immunization has proven to be one of public health's most cost-effective interventions. Measles surveillance and increase global coverage with two doses of measles vaccine through substantial and sustained additional investments in health systems are urgent efforts to achieve the regional elimination goals. Additional evaluation of the cost of two-dose schedules and its serological can provide valuable information for eventual global eradication.
  1 in total

Review 1.  Measles.

Authors:  William J Moss
Journal:  Lancet       Date:  2017-06-30       Impact factor: 79.321

  1 in total
  7 in total

1.  One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China.

Authors:  Qing Wang; Xiaoping Cheng; Dandan Liu; Changhui Chen; Kaihu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 4.526

2.  Anti-vaccination movements in the world and in Brazil.

Authors:  Isadora Sousa de Oliveira; Larissa Soares Cardoso; Isabela Gobbo Ferreira; Gabriel Melo Alexandre-Silva; Beatriz de Cássia da Silva Jacob; Felipe Augusto Cerni; Wuelton Marcelo Monteiro; Umberto Zottich; Manuela Berto Pucca
Journal:  Rev Soc Bras Med Trop       Date:  2022-05-20       Impact factor: 2.141

3.  Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019.

Authors:  Ruitong Wang; Wenzhan Jing; Min Liu; Jue Liu
Journal:  Front Med (Lausanne)       Date:  2022-01-20

4.  Measles resurgence in Brazil: analysis of the 2019 epidemic in the state of São Paulo.

Authors:  Cristina Makarenko; Alexandre San Pedro; Natalia Santana Paiva; Jefferson Pereira Caldas Dos Santos; Roberto de Andrade Medronho; Gerusa Gibson
Journal:  Rev Saude Publica       Date:  2022-06-13       Impact factor: 2.772

5.  Less than one-fifth of Ethiopian children were vaccinated for measles second dose; evidence from the Ethiopian mini demographic and health survey 2019.

Authors:  Atalay Goshu Muluneh; Mehari Woldemariam Merid; Bethelihem Tigabu; Menberesibhat Getie Ferede; Getahun Molla Kassa; Yaregal Animut
Journal:  Vaccine X       Date:  2022-09-14

6.  [Seroprevalence of antibodies against measles virus in Galicia: trends during the last ten years depending on age and sex].

Authors:  J J Costa-Alcalde; R Trastoy-Pena; G Barbeito-Castiñeiras; D Navarro de la Cruz; B Mejuto; A Aguilera
Journal:  Rev Esp Quimioter       Date:  2020-03-02       Impact factor: 1.553

7.  Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements.

Authors:  Juan P Aguilar Ticona; Nivison Nery; Renato Victoriano; Mariam O Fofana; Guilherme S Ribeiro; Emanuele Giorgi; Mitermayer G Reis; Albert I Ko; Federico Costa
Journal:  Vaccines (Basel)       Date:  2021-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.